SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
Antonio C. Fuentes-Fayos(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Raúl M. Luque(Instituto de Salud Carlos III)
Cited by 40
Related Papers
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
|Brain|2020|103
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
|EBioMedicine|2023|45
Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and <scp>IGF</scp>1
|Journal of Cellular and Molecular Medicine|2017|23